Physician profile
Andrew Mark Klapper
NPI 1497719819
$10,214.85
in general payments reported to CMS, 2019-2025
21 companies · $1,927 in 2025
The $1,927 reported for 2025 was more than what 83% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,107 · 2020: $1,550 · 2021: $561 · 2022: $913 · 2023: $1,859 · 2024: $2,298 · 2025: $1,927.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,541 · Travel and Lodging: $543.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,540.72 |
| Travel and Lodging | $542.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $3,503.79 | 2023-2025 | |
| Depuy Synthes Sales INC. | $1,464.73 | 2019-2025 | Na, Matrixrib |
| Baxter Healthcare | $1,169.68 | 2019-2020 | |
| Axogen | $974.99 | 2023 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
| Kerecis Limited | $522.86 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $505.95 | 2021-2025 | Dupixent |
| Sanara Medtech INC. | $294.97 | 2021-2022 | |
| Polynovo North America LLC | $268.37 | 2019-2025 | Novosorb Btm |
| Mentor Worldwide LLC | $262.14 | 2021-2024 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Genzyme Corporation | $230.03 | 2021-2022 | |
| Organogenesis INC. | $189.45 | 2021-2024 | Apligraf |
| Tela Bio, INC. | $172.27 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Acera Surgical, INC. | $153.35 | 2024 | Restrata Wound Matrix |
| Kci USA, INC. | $124.92 | 2023 | Prevena, V.A.C. Veraflo |
| Acell, INC. | $111.65 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polarityte, INC. | $81.43 | 2019 | |
| Ethicon US, LLC | $52.26 | 2019 | |
| Merz North America, INC. | $45.27 | 2019 | |
| Smith+Nephew, INC. | $41.29 | 2023 | Renasys Go V2 Home, Pico, Collagenase Santyl |
| Vertex Pharmaceuticals Incorporated | $25.62 | 2025 | |
| Medtronic USA, INC. | $19.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Klapper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.